Caribou Biosciences annual return on equity
2021
2022
2023
2024
2025
Caribou Biosciences Return on Equity (ROE) Growth & History (CRBU)
Caribou Biosciences's return on equity was −78.97% for fiscal 2025.
View full Caribou Biosciences company overviewCaribou Biosciences annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −78.97% | −30.98 pp |
| 2024 | 2024-12-31 | −47.99% | −17.49 pp |
| 2023 | 2023-12-31 | −30.50% | −1.63 pp |
| 2022 | 2022-12-31 | −28.87% | +7.86 pp |
| 2021 | 2021-12-31 | −36.73% | — |
Caribou Biosciences quarterly return on equity
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −24.27% | +3.96 pp |
| Q1 2026 | 2026-03-31 | −22.38% | −5.37 pp |
| Q4 2025 | 2025-12-31 | −20.07% | −6.78 pp |
| Q3 2025 | 2025-09-30 | −17.89% | −6.17 pp |
| Q2 2025 | 2025-06-30 | −28.22% | −16.69 pp |
| Q1 2025 | 2025-03-31 | −17.01% | −5.42 pp |
| Q4 2024 | 2024-12-31 | −13.29% | −4.29 pp |
| Q3 2024 | 2024-09-30 | −11.72% | −8.73 pp |
| Q2 2024 | 2024-06-30 | −11.53% | −0.75 pp |
| Q1 2024 | 2024-03-31 | −11.59% | −1.90 pp |
| Q4 2023 | 2023-12-31 | −9.00% | −0.36 pp |
| Q3 2023 | 2023-09-30 | −3.00% | +4.93 pp |
| Q2 2023 | 2023-06-30 | −10.78% | −3.36 pp |
| Q1 2023 | 2023-03-31 | −9.68% | −4.66 pp |
| Q4 2022 | 2022-12-31 | −8.64% | −3.97 pp |
| Q3 2022 | 2022-09-30 | −7.93% | +3.83 pp |
| Q2 2022 | 2022-06-30 | −7.42% | — |
| Q1 2022 | 2022-03-31 | −5.03% | — |
| Q4 2021 | 2021-12-31 | −4.67% | — |
| Q3 2021 | 2021-09-30 | −11.76% | — |
Caribou Biosciences return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Caribou Biosciences's return on equity decreased from −36.73% to −78.97%, a change of −42.24 percentage points. The latest reported quarter, Q2 2026, shows −24.27%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Caribou Biosciences source filings ↗